The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The goal is to better support drug developers as programs move from laboratory research into clinical trials
To boost compostable packaging, resin innovation, and supply chain speed
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
Paves the way for next-gen ultra-precise gas sensing
A major push to sharpen the future of cancer treatment is underway
Subscribe To Our Newsletter & Stay Updated
